Nidan Laboratories and Healthcare Limited — Others, 05-04-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Nidan Laboratories and Healthcare Limited has communicated that Corporate Governance provisions under SEBI regulations are not applicable for the quarter ended March 31, 2025, due to the company's listing on the SME portal. This exemption may allow Nidan to streamline its operational processes and potentially reduce compliance costs. From an investor standpoint, this could indicate a positive outlook in terms of operational efficiency, albeit it may raise questions about governance practices that investors typically look for. Overall, the announcement suggests a focus on enhancing operational agility without the added burden of extensive governance compliance.